Skip to content
Screener

Discontinued — last reported Q3 '22

Debt-to-equity at other companies

Tenet Healthcare logo
Tenet HealthcareTHC
2.9×-0.7×
Johnson & Johnson logo
Johnson & JohnsonJNJ
0.6×-0.1×
Merck & Co. logo
Merck & Co.MRK
1.1×+0.3×
Insmed logo
InsmedINSM
0.8×-10.7×
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
0.2×0.0×
LQD
Liquidia CorporationLQDA
0.1×-0.1×

Other financials

Income statement

See full
Revenue$781.5M-1.6%
Gross profit$648.1M-7.7%
Operating income$325.8M-14.9%
Net income$274.9M-14.7%
EPS (diluted)$5.82-12.2%

Balance sheet

See full
Cash & equivalents$1.3B-32.6%
Total debt$12.2M
Total equity$5.9B-13.3%
Total assets$6.7B-13.3%

Cash flow

See full
Operating cash flow$463.3M+0.5%
CapEx$100.8M+34.6%
Free cash flow$362.5M-6.2%

Valuation

See full
Market cap$21.98B+66.0%
P/E17.1×+6.4×
P/S6.9×+2.6×

Profitability

See full
Gross margin86.6%-2.4pp
Operating margin45.3%-1.6pp
Net margin40.6%+0.2pp
FCF margin32.1%-5.6pp

Returns & leverage

See full
Return on equity20.3%+0.3pp
Current ratio4.8×-0.7×

Where this comes from

Calculated from United Therapeutics’s reported figures.

Based on the most recent quarter.

The source filing: United Therapeutics’s 10-Q, filed November 2, 2022. Open the filing →

Filed
Nov 1, 2022, 8:00 PM EDT
Fiscal quarter
Q3 FY2022
Calendar quarter
Q3 2022
Accession
0001082554-22-000026

FAQ

What is United Therapeutics's debt-to-equity?
United Therapeutics (UTHR) reported debt-to-equity of 0× in Q3 2022.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.

Ask your AI about United Therapeutics's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude